KCA: Small Study Shows 90% Benefit Rate in Papillary Kidney Cancer - MedPage Today PDF Print
MedPage TodayCHICAGO -- Almost all patients with papillary renal carcinoma had stable disease or better response to treatment with a drug that targets multiple growth

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.